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VEGF induces signalling and angiogenesis by directing VEGFR2
internalisation through macropinocytosis
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ABSTRACT
Endocytosis plays a crucial role in receptor signalling. VEGFR2 (also
known as KDR) and its ligand VEGFA are fundamental in
neovascularisation. However, our understanding of the role of
endocytosis in VEGFR2 signalling remains limited. Despite the
existence of diverse internalisation routes, the only known endocytic
pathway for VEGFR2 is the clathrin-mediated pathway. Here, we
show that this pathway is the predominant internalisation route for
VEGFR2 only in the absence of ligand. Intriguingly, VEGFA induces
a new internalisation itinerary for VEGFR2, the pathway of
macropinocytosis, which becomes the prevalent endocytic route
for the receptor in the presence of ligand, whereas the contribution of
the clathrin-mediated route becomes minor. Macropinocytic
internalisation of VEGFR2, which mechanistically is mediated
through the small GTPase CDC42, takes place through
macropinosomes generated at ruffling areas of the membrane.
Interestingly, macropinocytosis plays a crucial role in VEGFA-
induced signalling, endothelial cell functions in vitro and
angiogenesis in vivo, whereas clathrin-mediated endocytosis is not
essential for VEGFA signalling. These findings expand our
knowledge on the endocytic pathways of VEGFR2 and suggest that
VEGFA-driven internalisation of VEGFR2 through macropinocytosis
is essential for endothelial cell signalling and angiogenesis.
KEY WORDS: Endocytosis, Macropinocytosis, Membrane
trafficking, Signalling, VEGF, VEGFR2
INTRODUCTION
It was originally thought that the plasma membrane is the exclusive
place from where the ligand–receptor complexes activate
downstream signalling cascades. In this view, endocytosis was
considered to cause termination of signalling by directing the
receptors to lysosomes for degradation. However, it is now evident
that a number of receptors explore the endocytic routes in order to
tune the duration, amplitude and specificity of the signalling process
(McMahon and Boucrot, 2011; Miaczynska et al., 2004; Sorkin and
von Zastrow, 2009).
VEGFR2 (also known as KDR) is a major angiogenic receptor
that plays a crucial role in blood vessel homeostasis and vascular
diseases (Herbert and Stainier, 2011; Olsson et al., 2006).
Additionally, VEGFR2-triggered angiogenesis is a hallmark of
cancer progression and metastasis (Herbert and Stainier, 2011;
Olsson et al., 2006). Numerous previous studies have contributed to
a remarkable knowledge regarding the signalling cascades that are
activated by VEGF and their importance in VEGF-mediated
functions. However, our understanding on the different routes that
are responsible for VEGFR2 internalisation remains limited. Thus,
until now, the only known endocytic route for VEGFR2 has been
the canonical clathrin-mediated pathway (Bhattacharya et al., 2005;
Bruns et al., 2010, 2012; Ewan et al., 2006; Gourlaouen et al., 2013;
Lampugnani et al., 2006; Lee et al., 2014; Nakayama et al., 2013;
Pasula et al., 2012; Sawamiphak et al., 2010; Tessneer et al., 2014),
and its importance in VEGF signalling is debated (Bruns et al.,
2010; Gourlaouen et al., 2013; Lampugnani et al., 2006; Lee et al.,
2014; Pasula et al., 2012; Tessneer et al., 2014). Intriguingly,
VEGF-induced degradation of VEGFR2 persists upon inhibition of
clathrin-mediated endocytosis (CME) (Bhattacharya et al., 2005;
Fearnley et al., 2016; Gourlaouen et al., 2013; Pasula et al., 2012;
Tessneer et al., 2014), thereby suggesting that the receptor might
also internalise through clathrin-independent endocytic routes, a
possibility that remains unexplored.
To unambiguously address the role of endocytosis in VEGFR2
function, here we identified the different endocytic itineraries of
VEGFR2 and tested their functional significance in signalling. Our
findings suggest that CME is only the main endocytic route of
VEGFR2 in the absence of ligand, whereas addition of VEGF (the
VEGFA isoform VEGF165a) induces a new internalisation
itinerary for VEGFR2, the route of macropinocytosis, which is
essential for VEGF signalling, endothelial cell functions and
angiogenesis.
RESULTS
Although constitutive internalisation of VEGFR2 is clathrin
mediated, VEGF induces a new clathrin-independent
internalisation route for the receptor
To systematically analyse the internalisation routes of VEGFR2, we
studied the pathways of endocytosis both in the absence of ligand
(constitutive, steady-state internalisation) and in the presence of
VEGFA, in primary endothelial cells (HUVECs). The isoform of
VEGFA used throughout the present study is VEGF165a, the most
well-studied ligand of VEGFR2 (Olsson et al., 2006), and is
hereafter called simply VEGF. To track the internalisation itineraries
of VEGFR2, at first we employed a microscopy-based anti-
VEGFR2 antibody uptake assay in live cells (Gourlaouen et al.,
2013; Lampugnani et al., 2006; Sawamiphak et al., 2010), followed
by an acid-wash step to strip the antibody that remained associated
with the plasma membrane (this method does not interfere withReceived 16 February 2016; Accepted 13 September 2016
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VEGF signalling and VEGFR2 phosphorylation; data not shown).
Given that, apart from plasma membrane localisation, a significant
amount of VEGFR2 is localised at the Golgi and endosomal
compartments (Gampel et al., 2006; Manickam et al., 2011), this
assay allows detection of newly internalised receptor molecules,
without interference from the intracellular or non-internalised pools
of VEGFR2. Using this experimental approach, we confirmed that
VEGFR2 internalises, even in the absence of VEGF, in a clathrin-
dependent manner (Fig. 1A) (Basagiannis and Christoforidis, 2016;
Ewan et al., 2006). However, unlike constitutive endocytosis,
VEGF-stimulated internalisation of VEGFR2 was, unexpectedly,
only partially inhibited by the small interfering RNA (siRNA)
knockdown of the clathrin heavy chain (CHC, also known as CLTC)
(Fig. 1B) (similar data were obtained by a second siRNA against
CHC, Fig. S1A). These data were confirmed by an independent
methodological approach, which is based on a biotin pulldown
assay that detects the remaining VEGFR2 at the cell surface, post-
VEGF activation. By employing this technique, we found that
VEGF causes an increase in the amount of internalised VEGFR2,
whereas CHC knockdown was unable to substantially interfere
with the uptake of the receptor (Fig. 1C). To further evaluate the
contribution of CME in VEGF-induced internalisation, we
developed, based on previous reports (Bator and Reading, 1989;
Smith et al., 1997), an ‘ELISA-like’ assay that quantitatively
assesses the levels of VEGFR2 at the cell surface. In line with the
above data, knockdown of CHC only partially reduced the uptake of
the receptor (Fig. 1D), which suggests that VEGF induces a clathrin-
independent route of internalisation for VEGFR2. Endocytosis via
caveolae [plasma membrane invaginations, where VEGFR2 had
been found to be localised (Lajoie and Nabi, 2010; Mayor and
Pagano, 2007; Parton and del Pozo, 2013; Pelkmans et al., 2004;
Shvets et al., 2014)] is not responsible for this new route of
internalisation, because knockdown of caveolin-1 had no effect on
VEGF-induced endocytosis of VEGFR2 (Fig. 1C,D).
To further test the contribution of CME in VEGF-induced
endocytosis of VEGFR2, we investigated the involvement of
dynamin 2, a well-established mediator of this pathway (Sever et al.,
2000). Knockdown of dynamin 2 had no effect on the internalisation
of VEGFR2, as revealed by the microscopy- or the biotinylation-
based approach (Fig. S1B,C, respectively). Furthermore,
knockdown of either dynamin 2 or CHC had no substantial effect
on VEGF-induced degradation of VEGFR2 (Fig. S1D), which is
in line with the conclusion that internalisation (and further
degradation) of VEGFR2 takes place in a dynamin- and clathrin-
independent manner.
The above data, which suggests that constitutive internalisation
of VEGFR2 is mediated by clathrin whereas VEGF induces
a clathrin-independent route of internalisation, were further
supported by using total internal reflection fluorescence
microscopy (TIRF-M) in live cells expressing VEGFR2–
mCherry. In the absence of VEGF, addition of dynasore, a
rapidly acting inhibitor of dynamin (Macia et al., 2006), which
blocks both clathrin and caveolae-mediated internalisation, led to
an increase of VEGFR2 levels at the cell surface (compare left and
middle images of Fig. S1E, see also Movie 1). Addition of VEGF
caused a loss of the cell surface signal, suggesting that VEGF
induces a dynamin-independent route of entry (compare right and
middle images of Fig. S1E, see also Movie 1). Taken together, the
above data suggest that, although in the absence of ligand the
receptor internalises mainly in a clathrin-dependent manner, VEGF
induces a new clathrin-independent route of internalisation for
VEGFR2.
VEGF induces membrane ruffling and internalisation of
VEGFR2 through macropinocytosis
A hint about the identity of the new clathrin-independent route of
VEGFR2 came from the observation that, following activation by
VEGF, the size of a significant number of VEGFR2-positive
endosomes was considerably larger than the size of endosomes
carrying constitutively internalised VEGFR2 (presented in detail in
the subsequent figures). A route that is well-known for generating
large endocytic vesicles is macropinocytosis (Kerr and Teasdale,
2009; Mayor and Pagano, 2007; Mercer and Helenius, 2009). To test
whether VEGF induces macropinocytic internalisation of VEGFR2,
as well as to exclude the possibility that the clathrin-independent
internalisation of the receptor is due to the induction of compensatory
endocytic pathways (Damke et al., 1995) (as a consequence of the
long-term inhibition of CME), we employed a number of
experiments, in the absence of any perturbation of endocytic routes.
First, given that macropinocytosis initiates at sites where
membrane ruffling and actin reorganisation takes place (Kerr and
Teasdale, 2009), we employed dual-colour video microscopy to
analyse the spatio-temporal coordination of the cell membrane
dynamics (followed by GFP–actin) with receptor endocytosis
(monitored by VEGFR2–mCherry). Interestingly, upon activation
with VEGF, we observed sites of the membrane undergoing intense
membrane ruffling (seen by the dynamics of GFP–actin), followed
by the formation of large vesicles that were positive for both actin
and VEGFR2 (see Movie 2 and Fig. 2A). Actin was only transiently
present at these vesicles, that is, from the beginning of their
generation until they were fully formed.
Second, we quantified the size, the number and the fluorescence
intensity of the vesicles containing VEGFR2, in quiescent and
VEGF-stimulated cells. Interestingly, VEGF caused a striking
increase of the content of VEGFR2 (relative fluorescence of
VEGFR2) in large-sized vesicles along with an increase of the
number of these vesicles (Fig. 2B).
Third, as a complementary approach, we analysed by electron
microscopy, the morphology and the size of vesicles containing
VEGFR2. In VEGF-activated cells, there was a significant increase
over time of the signal of VEGFR2 (number of gold particles) in
vesicles whose size was over 0.2 μm (Fig. 2C).
Subsequently, fourth, we tested the colocalisation of internalised
VEGFR2 with known markers of macropinosomes. Induction by
VEGF led to internalisation of VEGFR2 in endosomes that were
positive for high-molecular-mass dextran (Fig. 3A), an established
cargo and marker of macropinosomes (Mercer and Helenius, 2009;
Schnatwinkel et al., 2004). Additionally, VEGFR2 colocalised with
rabankyrin-5 (Fig. 3A), an endosomal protein that, besides being
localised to diverse endocytic vesicles (Fabrowski et al., 2013; Ishii
et al., 2003; Schnatwinkel et al., 2004; Zhang et al., 2012), also
localises to macropinosomes (Schnatwinkel et al., 2004). We also
tested the colocalisation of internalised VEGFR2 with EEA1, a
marker of the early endosomes (Mu et al., 1995). Triple labelling
analysis revealed that a number of vesicles double-positive for
VEGFR2 and rabankyrin-5 were either negative or only poorly
stained for EEA1 (Fig. S2A), which is consistent with previous
findings showing that macropinosomes are only weakly or not at all
positive for EEA1 (Schnatwinkel et al., 2004). Notably, given that
the above four independent experimental approaches (Figs 2A–C,
3A; Movie 1) are employed in the absence of any perturbation of
endocytosis, we conclude that macropinocytosis of VEGFR2 is not
a compensatory endocytic pathway that takes place as a
consequence of the long-term inhibition of CME (Damke et al.,
1995), but is rather due to the ability of VEGF to induce
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Fig. 1. See next page for legend.
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macropinocytic internalisation of its receptor. Interestingly,
although knockdown of rabankyrin-5 did not significantly affect
the uptake of the receptor (Fig. S2B,C), it attenuated its degradation
(Fig. S2D), suggesting that, following macropinocytosis, a fraction
of the receptor pool is targeted for degradation.
Finally, fifth, we tested the effect of EIPA, a commonly used
inhibitor of macropinocytosis (Commisso et al., 2014; Kerr and
Teasdale, 2009; Koivusalo et al., 2010; Kuhling and Schelhaas,
2014), on VEGF-induced internalisation of VEGFR2. Treatment
with EIPA caused a substantial decrease of endocytosis of both
VEGFR2 and dextran, as well as a reduction of the number of the
large VEGFR2-positive vesicles (Fig. 3B), whereas internalisation
in small vesicles was not substantially affected (Fig. 3B).
Concomitant treatment with EIPA and dynasore resulted in an
almost complete inhibition of the internalisation of VEGFR2 in
large as well as in small vesicles (Fig. 3B), suggesting that, although
macropinocytosis is the main internalisation route of VEGFR2, a
fraction of the receptor is internalised by CME. To quantify the
relative contribution of macropinocytosis and CME in VEGFR2
internalisation, we employed the ELISA-like assay described above,
which determines the surface levels of VEGFR2 in intact cells. We
found that the inhibitory effect of EIPAwas approximately two-fold
higher than that of dynasore (EIPA and dynasore inhibited
internalisation by 70% and 30%, respectively), and that the two
inhibitors together completely blocked the uptake of the receptor,
suggesting that CME and macropinocytosis are the sole routes of
VEGFR2 internalisation (Fig. 3C). Thus, several lines of evidence
suggest that, upon induction with VEGF, macropinocytosis
accounts for ∼70% of VEGFR2 internalisation whereas only 30%
of the receptor is internalised by CME (Figs 1B–D, 3C). Based on
all the above, macropinocytosis emerges here as a new route for
VEGF-induced entry of VEGFR2, which, although it operates in
parallel to CME, is the preferred endocytic route of this receptor.
Macropinocytosis of VEGFR2 is mediated by the small
GTPase CDC42
To get insights into the mechanism of macropinocytosis of
VEGFR2, as well as to further validate the macropinocytic
internalisation of this receptor, we tested the involvement of the
small GTPase CDC42, a known regulator of macropinocytosis
(Chen et al., 1996; Fiorentini et al., 2001; Garrett et al., 2000;
Koivusalo et al., 2010). Indeed, treatment of HUVECs with siRNAs
against CDC42 inhibited internalisation of both high-molecular-
mass dextran (known cargo of macropinocytosis) and VEGFR2
(Fig. 4A). Additionally, using the biochemical biotinylation assay,
we found that knockdown of CDC42 attenuated the uptake of the
receptor (Fig. 4B). Finally, knockdown of CDC42 significantly
delayed VEGF-induced degradation of VEGFR2 (Fig. 4C) (similar
data were obtained using a second siRNA against CDC42;
Fig. S3A,B). These data not only suggest that the mechanism of
macropinocytosis of VEGFR2 involves the function of the GTPase
CDC42, but also further substantiate that this receptor is
endocytosed through macropinocytosis.
Macropinocytosis is crucial for VEGF signalling, endothelial
cell functions and angiogenesis
We then proceeded to address the significance of both CME and
macropinocytosis, in VEGF-induced signalling and endothelial cell
functions. Consistent with the minor contribution of CME (up to
30%) in VEGF-induced endocytosis of VEGFR2 (Figs 1B–D, 3C;
Fig. S1A–C), inhibition of this route by knockdown of CHC had no
effect on ERK1 and ERK2 (ERK1/2, also known as MAPK3 and
MAPK1, respectively) or Akt phosphorylation (all Akt isoforms)
(Fig. 5A) (similar data were obtained by a second siRNA against
CHC, Fig. S4A). Likewise, interference with the function of
dynamin, either by knockdown of dynamin 2 (Fig. 5B) or by
overexpression of dynamin-K44A (Fig. S4B), had no substantial
effect on ERK1/2 or Akt phosphorylation. A minor inhibition of Akt
phosphorylation by overexpression of dynamin K44A (Fig. S4B)
could be explained by the additional role of dynamin in signalling,
which is independent from its well-established function in vesicle
budding (Fish et al., 2000). Collectively, these data suggest that CME
of VEGFR2 is not essential for VEGF-induced signalling.
Interestingly, in keeping with the predominant contribution of
macropinocytosis in VEGFR2 internalisation (∼70%, Fig. 3C),
treatment with EIPA resulted in a strong inhibition of ERK1/2 and
Akt phosphorylation (Fig. 6A, top panels). Furthermore, and
consistent with the involvement of CDC42 in VEGFR2
macropinocytosis (Fig. 4A–C), knockdown of this GTPase led to a
substantial inhibition of VEGF-induced signalling (Fig. 6A, bottom
panels). To further evaluate the importance of macropinocytosis in
VEGF-mediated functions, we tested whether inhibition of
macropinocytosis influences VEGF-induced endothelial cell
properties. Indeed, inhibition of macropinocytosis by either EIPA
or knockdown of CDC42 blocked VEGF-induced endothelial cell
sprouting (Fig. 6B), migration (Fig. 6C; Fig. S4C) and survival
(Fig. 6D), whereas knockdown of CHC or dynamin 2 had no
substantial effect (Fig. 6B–D; Fig. S4C). Minor effects of the
knockdown of dynamin (but not of CHC) in endothelial cell
sprouting (Fig. 6B), or of the knockdown of CHC (but not of
dynamin) in endothelial cell survival (Fig. 6D), could be due to an
independent role of these trafficking regulators on the transport of
crucial molecules (other than VEGFR2), as proposed recently (Lee
et al., 2014). Consistent with this view, the knockdown of dynamin
interfered with basal endothelial cell migration, without affecting the
dependence onVEGF (Fig. 6C). In addition, the minor effect of CHC
knockdown on cell survival (Fig. 6D) might be due to the fact that
inhibition of CME causes a reduction in the levels of VEGFR2
(Fig. 1C; Basagiannis andChristoforidis, 2016; Fearnley et al., 2016).
Finally, in line with the above in vitro data, EIPA blocked VEGF-
induced formation of new blood vessels in matrigel angiogenesis
Fig. 1. VEGF induces a clathrin- and dynamin-independent internalisation
pathway for VEGFR2.HUVECs treatedwith siRNAs (knock down, k.d.) against
CHC were incubated with a mouse anti-VEGFR2 extracellular domain antibody
at 4°C, transferred to 37°C and the receptor was allowed to internalise for
15 min, in the absence (A) or the presence (B) of VEGF and FITC–transferrin.
Prior to fixation, membrane-bound antibodies and transferrin were removed by
acid wash and the internalised receptor was revealed by fluorescently labelled
secondary antibodies using confocal microscopy. Inhibition of transferrin uptake
verified the effective inhibition of clathrin-mediated endocytosis. Quantification
of VEGFR2 internalisation (relative to initial VEGFR2 levels in non-stimulated
cells) is shown on the right of immunofluorescence images. The data shown are
representative of three independent experiments (n=15 cells, mean±s.d.).
***P<0.001; ns, not significant (t-test). Scale bars: 10 μm. (C) CHCor caveolin-1
siRNA-treated HUVECs were incubated with VEGF for 15 min, transferred to
4°C and surface proteins were labelled with cell-impermeable biotin. Surface
biotinylated proteins were pulled down by streptavidin-conjugated beads and
analysed by immunoblotting. Surface VEGFR2 was revealed using rabbit anti-
VEGFR2 antibodies. Quantification of VEGFR2 is shown on the right of the
immunoblots (n=3, mean±s.d.). ns, not significant (one-way ANOVA, Dunnett).
(D)Quantitative ELISA-like assayof surfaceVEGFR2 in cells treatedwith siRNA
against CHCor caveolin-1 upon inductionwith VEGF (30 min). Values represent
the percentage (%) of the receptor that remains at the plasma membrane of
stimulated cells, compared to the levels in quiescent cells. Data shown are
representative of three independent experiments performed in quadruplicates
(mean±s.d.). **P<0.01; ns, not significant (one-way ANOVA, Dunnett).
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Fig. 2. VEGF induces the internalisation of VEGFR2 in large endocytic vesicles. (A) Live-cell time-lapse video microscopy of HUVECs expressing GFP–
actin and mCherry–VEGFR2. Magnified images show the VEGF-induced progressive formation of an enlarged VEGFR2-positive vesicle (mCherry–VEGFR2),
driven by extensive membrane ruffling (GFP–actin). Scale bar: 3 μm. See also Movie 2. (B) Analysis of the effect of VEGF on the number and fluorescence
intensity of VEGFR2-positive vesicles. The number of VEGFR2-positive vesicles (lower graph) and the intensity of VEGFR2 fluorescence (upper graph) is
presented (as a fold increase over constitutive internalisation) in relation to the size of the vesicles. The data shown are derived from three independent
experiments (n=20 cells, mean±s.d.). ***P<0.001, **P<0.01 and *P<0.05 (t-test). (C) Electron microscopy analysis of VEGFR2-positive vesicles. Immunogold
labelling of VEGFR2 (5-nm gold particles, arrowheads) on ultrathin cryosections of HUVECs stimulated with VEGF for 10 (left) or 20 min (right). Scale bars:
500 nm. The graph on the right shows quantification of the number of gold particles (n=250) in vesicles below or above 0.2 μm, after 10 or 20 min of treatment with
VEGF. Thewhite bars show the number of gold particles in vesicles that have size <0.2 μm; the black bars show the gold particles in large vesicles >0.2 μm (n=3,
mean±s.d.). *P<0.05, **P<0.01 (t-test).
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assays in mice (Fig. S4D), as well as in corneal neovascularisation
assays in rabbits (Fig. S4E). Overall, these data suggest that
macropinocytosis is critical for VEGF-induced signalling,
endothelial cell functions and angiogenesis.
DISCUSSION
Here, we found that the preferred internalisation itinerary of
VEGFR2 upon induction with VEGF is distinct from the
internalisation route that the receptor follows constitutively (see
model in Fig. 7). Without ligand, VEGFR2 is mainly endocytosed
in a clathrin-dependent manner, whereas, unexpectedly, VEGF
causes a switch in the preference of the internalisation of VEGFR2
towards macropinocytosis, an endocytic route that is crucial for
downstream signalling to ERK1/2 and Akt, for endothelial cell
functions and for angiogenesis in vivo.
To date, the sole known route of internalisation for VEGFR2 is
the clathrin- and dynamin-mediated endocytosis (Bhattacharya
et al., 2005; Bruns et al., 2010; Ewan et al., 2006; Gourlaouen et al.,
2013; Lampugnani et al., 2006; Lee et al., 2014; Nakayama et al.,
2013; Pasula et al., 2012; Sawamiphak et al., 2010; Tessneer et al.,
Fig. 3. VEGF induces a preferential
internalisation of VEGFR2
through macropinocytosis.
(A) Immunofluorescence microscopy
analysis of VEGFR2 colocalisation with
dextran and rabankyrin-5. HUVECs were
incubated with an anti-VEGFR2 antibody
at 4°C and were transferred to 37°C for
15 min, in the presence of 70 kDa dextran,
without (top) or with VEGF (bottom). Cells
were acid washed, then fixed and stained
for endogenous rabankyrin-5. The fold
increase in induction of internalisation of
VEGFR2, upon treatment with VEGF, is
indicated in the inset text in the bottom left
image. Scale bars: 10 μm.
(B) Immunofluorescence microscopy
analysis of VEGFR2 internalisation upon
inhibition of macropinocytosis. HUVECs
labelled as in A were treated with vehicle
(top) or EIPA (middle) or EIPA+dynasore
(bottom) and stimulated with VEGF
(15 min), in the presence of 70 kDa
dextran. Cells were acid washed, then
fixed and stained for endogenous
rabankyrin-5. Scale bars: 10 μm.
Quantification of the number and size of
VEGFR2-positive vesicles is shown on the
right of the immunofluorescence images.
The data shown are representative of
three independent experiments (n=15
cells, mean±s.d.) (C) Quantitative ELISA-
like assay of surface VEGFR2. Effect of
inhibition of dynamin (by dynasore) or of
macropinocytosis (by EIPA) or of dynamin
and macropinocytosis (by
EIPA+dynasore) on the internalisation of
VEGFR2. HUVECs were treated for
30 min with vehicle or inhibitors,
stimulated with VEGF (30 min) and
assayed using surface ELISA. Data
shown are representative of three
independent experiments performed in
quadruplicates (mean±s.d.). **P<0.01,
***P<0.001 (one-way ANOVA, Dunnett).
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Fig. 4. Macropinocytosis of VEGFR2 ismediated by CDC42. (A) HUVECs were treated with siRNAs (knock down, k.d.) against CDC42, incubated with a mouse
anti-VEGFR2 extracellular domain antibody at 4°C and transferred to 37°C, where the receptor was allowed to internalise for 15 min, in the absence (left) or the
presence (right) of VEGF and 70 kDa dextran. Prior to fixation, membrane-bound antibodies and dextran were removed by acid wash and the internalised receptor
was revealed by incubation with fluorescently labelled secondary antibodies, using confocal microscopy. Quantification of VEGFR2 internalisation, from three
independent experiments, is shown on the right of the immunofluorescence images (n=30 cells, mean±s.d.). ***P<0.001 (t-test). Scale bars: 10 μm. (B) HUVECs
were treatedwith siRNAsagainstCDC42, incubatedwithVEGF for 15 min, transferred to4°Cand surface proteinswere labelledwith cell-impermeablebiotin. Surface
biotinylated proteinswere pulled down bystreptavidin-conjugated beads and analysed by immunoblotting. SurfaceVEGFR2was revealed using rabbit anti-VEGFR2
antibodies. Quantification of VEGFR2 internalisation is shown on the right of the immunoblots (n=3, mean±s.d.). ***P<0.001 (t-test). (C) HUVECs were treated with
siRNAs against CDC42, serum-starved for 2 h, incubated with 100 μm cycloheximide for 30 min and stimulated with VEGF for the indicated time intervals.
Quantification of VEGFR2 levels is shown on the right of the immunoblots (n=4, mean±s.d.). ***P<0.001 (two-way ANOVA, Bonferroni).
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2014). However, intriguingly, several studies have reported
that VEGFR2 degradation persists even when the clathrin
pathway is blocked (Bhattacharya et al., 2005; Fearnley et al.,
2016; Gourlaouen et al., 2013; Pasula et al., 2012; Tessneer et al.,
2014), which suggests that VEGFR2 is also internalised through a
route that is independent of clathrin. Indeed, the data presented
here suggest that, following activation with VEGF, the preferred
route of endocytosis of VEGFR2 is macropinocytosis, whereas,
unexpectedly, only a minor fraction of VEGFR2 internalises by
CME. Several lines of evidence support the macropinocytic
Fig. 5. Clathrin-mediated endocytosis is not essential for VEGF signalling. HUVECs transfected with siRNAs against CHC or caveolin-1 (cav1, A), or
dynamin 2 (dyn2, B), were stimulatedwith VEGFand subjected to immunoblotting analysis using antibodies against ERK1/2 andAkt [phosphorylated (p) or total].
The efficiency of dynamin 2 knockdown (k.d.) was determined by semi-quantitative RT-PCR, 60 h post transfection of the cells. Levels were normalised to
GAPDH. Bar graphs on the right show quantification of the immunoblots (n=3, mean±s.d.). ns, not significant (two-way ANOVA, Bonferroni).
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internalisation of VEGFR2. First, VEGF induces the formation of
large VEGFR2-positive vesicles at areas undergoing pronounced
membrane ruffling (as observed by live-cell microscopy). Second,
the size of these vesicles is compatible with the known large size of
macropinosomes (estimated by either confocal or electron
microscopy). Third, following activation with VEGF, internalised
VEGFR2 colocalised with dextran and rabankyrin-5. Finally,
fourth, VEGFR2 internalisation was largely inhibited by EIPA, a
Fig. 6. See next page for legend.
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commonly used inhibitor of macropinocytosis (Commisso et al.,
2014; Kerr and Teasdale, 2009; Koivusalo et al., 2010; Kuhling
and Schelhaas, 2014), or by knocking down the small GTPase
CDC42, a well-characterised mediator of macropinocytosis (Chen
et al., 1996; Fiorentini et al., 2001; Garrett et al., 2000; Koivusalo
et al., 2010).
Our data suggest that CME is not required for VEGF signalling to
ERK1/2 or to Akt, whereas macropinocytosis is crucial. This
finding is consistent with previous studies showing that CME is
not essential for VEGF-mediated activation of the downstream
signalling cascades (Bruns et al., 2010; Lampugnani et al., 2006;
Lee et al., 2014; Pasula et al., 2012; Tessneer et al., 2014). However,
in contrast to these data, other studies have reported that CME is
required for VEGF-mediated downstream signalling (Gourlaouen
et al., 2013; Nakayama et al., 2013). It is possible that these
differences are due to the different employed techniques, tools or
cell lines. In fact, differences in the importance of endocytosis
between primary endothelial cells and transformed cell lines has
been reported previously (Gourlaouen et al., 2013). Additionally, a
recent study has proposed that reduced VEGF signalling upon
depletion of CHC might be simply due to the enhanced degradation
of VEGFR2, rather than due to a direct effect of this trafficking route
in signalling (Fearnley et al., 2016). In any case, our findings are in
line with the predominant and most recent view that CME is not
required for VEGF signalling (Bruns et al., 2010; Lampugnani
et al., 2006; Lee et al., 2014; Pasula et al., 2012; Tessneer et al.,
2014). Thus, all in all, it appears that CME of VEGFR2 is not
necessary for signalling to ERK1/2 (Bruns et al., 2010; Lampugnani
et al., 2006; Lee et al., 2014; Pasula et al., 2012; Tessneer et al.,
2014; and present study) whereas macropinocytosis is absolutely
essential (present study).
Given that CME is the major route of constitutive endocytosis of
VEGFR2 (in the absence of ligand), an appealing question raised
from our findings is why does VEGF need to induce a new route of
internalisation for VEGFR2 (macropinocytosis). In other words,
how could one explain that CME of VEGFR2, unlike
macropinocytosis, is not able to support signalling? The inability
of CME to support signalling could be due to a lower efficiency of
CME in internalising VEGFR2, its failure to co-internalise
VEGFR2 with the necessary downstream molecules or, finally,
delivery of VEGFR2 to endosomal compartments that lack the
appropriate downstream molecules. By contrast, macropinocytosis
might allow VEGFR2 signalling by fulfilling one or more of the
above functions. It is tempting to speculate that macropinocytosis
might be responsible for delivering signalling complexes of the
receptor to downstream targets, such as ERK1/2 and Akt, that could
reside at specific endosomal compartments (Dobrowolski and De
Robertis, 2012; McKay and Morrison, 2007; Miaczynska et al.,
2004; Platta and Stenmark, 2011; Schenck et al., 2008; Sorkin and
von Zastrow, 2009; Teis et al., 2002; Zouggari et al., 2009).
Consequently, macropinocytosis would link VEGFR2 to the
downstream cascades required to regulate complex angiogenic
responses, such as survival (Karali et al., 2014), proliferation and
migration of endothelial cells (Herbert and Stainier, 2011).
A question that emerges from the present study is whether there are
cellular conditions that affect macropinocytosis of VEGFR2, thereby
influencing signalling, as well as whether macropinocytosis is the
only route regulating the output of VEGFR2. Several observations
provide the means to approach this issue. Different isoforms of
VEGFA ligands (VEGF165, VEGF145 and VEGF121) have been
found to exert differing effects on VEGFR2 signal transduction,
trafficking and proteolysis (Ballmer-Hofer et al., 2011; Fearnley
et al., 2016). Furthermore, VEGFR2 co-receptors, or other VEGFR2-
interacting proteins, co-internalise with, and/or regulate the
trafficking properties of, VEGFR2 (Ballmer-Hofer et al., 2011;
Chen et al., 2010; Holmes and Zachary, 2008; Koch et al., 2014;
Fig. 6. Macropinocytosis is crucial for VEGF signalling and in vitro
angiogenic responses. (A) Treatment with EIPA or knockdown (k.d.) of
CDC42 inhibits VEGF-induced activation of ERK1/2 and Akt. HUVECs treated
with vehicle or EIPA (upper panels) or HUVECs treated with siRNAs against
CDC42 (bottom panels) were stimulated with VEGF and subjected to
immunoblotting analysis using antibodies against ERK1/2 and Akt
[phosphorylated (p) or total]. Bar graphs on the right show quantification of the
immunoblots (n=3, mean±s.d.). *P<0.05, ***P<0.001 (two-way ANOVA,
Bonferroni). (B) VEGF-induced endothelial cell sprouting is inhibited by EIPA
or knockdown of CDC42. Left, HUVEC spheroids were embedded in 3D
collagen gels and were treated with vehicle or EIPA in the presence of VEGF
for 16 h (upper panel). Similarly, HUVEC spheroids derived from cells treated
with siRNAs against CDC42, CHC, or dynamin 2 (dyn2) were treated with
VEGF as above (lower panel). Images are representative of three independent
experiments. Quantification of the mean±s.d. sprout length of eight randomly
selected spheres for each experimental setting is shown on the right of the
images. **P<0.01, ***P<0.001 (t-test). (C) Knockdown of CDC42 or treatment
with EIPA abolishes VEGF-induced migration of endothelial cells. Confluent
HUVEC cultures of cells treated with siRNAs against CDC42, CHC or dynamin
2, or EIPA-treated cells (30 min), were scratched linearly with a pipette tip and
stimulated with VEGF for 14 h. VEGF untreated cells were analysed in parallel.
The bar graph depicts the average migration of the cells towards the centre of
the wound (distance in μm) (n=12 injury areas from three independent
experiments, mean±s.d.). ***P<0.001; ns, not significant (t-test). (D) VEGF-
induced survival of endothelial cells is CDC42 dependent. The cell viability of
HUVECs treated with siRNAs against CDC42, CHC or dynamin 2, was
assessed by an MTT assay. Bar graph depicts the percentage fold increase in
VEGF-induced survival of HUVECs relative to VEGF-untreated cells. Values
are representative of three independent experiments carried out in triplicates
(mean±s.d.). *P<0.05; ***P<0.001; ns, not significant (t-test).
Fig. 7. Model of the constitutive and stimulated internalisation routes of
VEGFR2 and their role in VEGFR2 function. Left, at steady state, quiescent
VEGFR2 is internalised through the clathrin-dependent internalisation route
(CME). Right, in the presence of VEGF, VEGFR2 is endocytosed through both
CME and macropinocytosis, the later being the preferred route.
Macropinocytosis of VEGFR2 is mediated by CDC42 and is crucial for VEGF-
induced signalling.
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Lampugnani et al., 2006; Lanahan et al., 2013, 2010; Nakayama
et al., 2013; Salikhova et al., 2008; Sawamiphak et al., 2010). Thus, it
is possible that different VEGF ligands might promote a differential
association between VEGFR2 and its co-receptors or interacting
partners, which might alter the balance between CME and
macropinocytosis of VEGFR2, or might even introduce additional
internalisation routes for the receptor. These processes could control
the diverse functions of the different types of endothelial cells, in
different tissues, throughout the different stages of development, a
hypothesis that warrants future investigations.
In the past years, macropinocytosis has emerged as a crucial
endocytic route for the function of growth factors that play an
essential role in the vascular tissue, that is FGF2 (Elfenbein et al.,
2012), PDGF (Schmees et al., 2012) and VEGF (present study).
Thus, given that inhibition of macropinocytosis results in a strong
inhibition of VEGF-induced angiogenesis in mice (present study),
interference with macropinocytosis opens up new perspectives in
anti-angiogenic cancer therapy and for treatment of other
angiogenesis-related diseases.
MATERIALS AND METHODS
Reagents and antibodies
The concentration of the reagents used in this study, unless stated otherwise,
is shown below in parentheses. Recombinant human VEGFA (isoform 165)
(50 ng/ml) was obtained from Immunotools; dynasore (100 µmol/l) and 5-
N-ethyl-N-isopropyl amiloride (EIPA) (50 µmol/l) were from Sigma-
Aldrich. Mouse and rabbit anti-VEGFR2 monoclonal antibodies were
from Abcam (ab9530, 1:100) and Cell Signaling (#2479, 1:2000),
respectively. The anti-actin antibody was from Millipore (MAB1501,
1:2000). Rabbit polyclonal antibodies against early endosome antigen 1
(EEA1) and rabankyrin-5 were kindly provided by Marino Zerial (MPI-
CBG, Dresden, Germany). The anti-clathrin heavy chain antibody was from
BD Biosciences (610499, 1:3000); the anti-caveolin-1 (sc-894, 1:1000) and
anti-CDC42 (sc-87, 1:200) antibodies were from Santa Cruz Biotechnology.
The antibodies against phosphorylated VEGFR2 (Tyr1175) (#2478, 1:1000)
ERK1/2 (#4695, 1:3000), phosphorylated ERK1/2 (#4370, 1:3000), Akt
(#9272, 1:1000) and phosphorylated Akt (#4060, 1:1000), were from Cell
Signaling. Secondary antibodies coupled to Alexa Fluor fluorophores were
from Invitrogen (1:400); horseradish peroxidase (HRP)-conjugated
antibodies were from Jackson Immunoresearch (1:1000). All other
reagents were obtained from Sigma-Aldrich, unless stated otherwise.
siRNAs, cDNAs and lentiviruses
The siRNAs for human clathrin heavy chain (siRNA A, 5′-GGGUGCCAG-
AUUAUCAAUUtt-3′; siRNA B, 5′-GGGAAGUUACAUAUUAUUGtt-3′)
were fromAmbion; the siRNAs for human CDC42 (target sequence of siRNA
A, 5′-GAUUACGACCGCUGAGUUA-3′ and target sequence of siRNA B,
5′-GGAGAACCAUAUACUCUUG-3′) and rabankyrin-5 (target sequence of
siRNA Α, 5′-GCAAAUCGGUUUCAGCUAC-3′ and target sequence of
siRNA Β, 5′-CAGAGUACCCGCUACAUAA-3′) were from Dharmacon.
The siRNAs for human dynamin-2 (5′-CAUGCCGAGUUUUUGCACUtt-
3′), human caveolin-1 (5′-AAGAGCUUCCUGAUUGAGAtt-3′) and control
siRNAs (Random DS) were from Biospring. CDC42 and dynamin-2 knock-
down experiments were carried out using 20 nmol/l of siRNAs. All other
knockdown experiments were carried out using 50 nmol/l of siRNAs. Cells
treated with siRNAs were assayed 60–72 h post transfection.
The cDNA of human VEGFR2 was kindly provided by Jacques Huot
(Centre de Recherche du CHU de Québec, Canada). The VEGFR2–
mCherry expression plasmid was generated by sub-cloning the cDNA of
human VEGFR2 in a pCMV-mCherry expression vector with standard
cloning procedures.
Lentiviruses of wild-type (wt) dynamin (1 and 2) or dynamin K44A (1
and 2) were generated according to a previously reported protocol (Tiscornia
et al., 2006). The cDNAs of dynamin 1 and 2 (both wt and K44A) were
kindly provided by Sandra Schmid (UT Southwestern, Dallas, Texas).
Human umbilical vein endothelial cells (HUVECs) were transduced at 50%
confluence in cell growth medium supplemented with 8 μg/ml polybrene.
The next day, medium was changed and cells were assayed 24–36 h post-
transduction. Transduction efficiency was determined by the fluorescence
of GFP, whose expression is controlled by the same promoter as dynamin.
The efficiency of dynamin 2 knockdown was assessed by semi-
quantitative RT-PCR. Total cellular RNA from HUVECs treated
with control or dynamin 2 siRNAs was isolated using a Nucleospin RNA
kit (Macherey-Nagel) and reverse-transcribed to cDNA using a PrimeScript
RT reagent Kit (Takara). The cDNA was then subjected to PCR
amplification with the following set of primers: dynamin 2 – forward:
5′-CAGAGCGTGTTTGCCAACAGTG-3′, reverse: 5′-TCGAGGCCTA-
GTCGAGCAGGGATG-3′, GAPDH forward: 5′-GTGGTCTCCTCTGA-
CTTCAAC-3′, reverse: 5′-ACCACCCTGTTGCTGTAGCC-3′. Amplification
of endogenous GAPDH was used as control of loading.
Cell treatments
HUVECs were isolated, cultured and transfected as previously described
(Zografou et al., 2012). Cells were routinely tested for contamination.
VEGF-dependent and -independent experiments were carried out using
cells deprived of serum for 2 h. Drug treatments were carried out in serum-
free M199 medium. Prior to VEGF stimulation, cells were treated with
vehicle (DMSO) or inhibitors, for 30 min.
Indirect immunofluorescence microscopy
HUVECs were cultured in 35-mm diameter plastic dishes (appropriate
for microscopy, by Ibidi), coated with collagen type I. Indirect
immunofluorescence and analysis by confocal microscopy was employed
as previously described (Papanikolaou et al., 2011). Images were captured
using a Leica TCS SP5 II scanning confocal microscope and a Leica 63X
HCX PL APO 1.4 NA objective. Data were subsequently processed in LAS
AF according to the manufacturer guidelines.
Microscopy-based internalisation assays
To monitor the internalisation fate of the endogenous cell surface pool of
VEGFR2, HUVECs that were starved for 2 h were transferred to 4°C and the
mediumwas replacedwith ice-cold blocking buffer [1%bovine serumalbumin
(BSA) in serum-freeM199medium bufferedwith 20 mmol/l HEPES]. After a
30-min pre-cooling step, cells were treated for 1 h with 10 μg/ml of mouse
anti-VEGFR2 extracellular domain antibodies. Cells were washed three times
with blocking buffer and transferred to 37°C in pre-warmed MI99 medium
supplemented with 1.5 mg/ml 70 kDa dextran conjugated to Texas Red or
50 μg/ml Fluorescein isothiocyanate (FITC)-conjugated transferrin
(Invitrogen), in the presence or absence of VEGF. Cells were acid washed
twice (ice-cold M199 medium, pH 2.0), and then fixed and processed for
immunofluorescence microscopy. The above protocol was also applied to
siRNA-treated cells. When inhibitors were used, following antibody
incubation, cells were treated with vehicle or inhibitors for 30 min at 4°C.
Biotinylation-based internalisation assays
To biochemically assess the amount of internalised VEGFR2, siRNA-
treated HUVECs that had been serum starved for 2 h were stimulated with
VEGF for 15 min, transferred to 4°C and labelled with 0.5 mg/ml EZ-Link
Sulfo-NHS-S-S-Biotin (Thermo-Scientific) at 4°C, for 20 min. Unbound
biotin was quenched with 50 mM glycine in PBS, cells were lysed in lysis
buffer (0.5% Triton X-100, 0.5% NP-40, 50 mM Tris-HCl pH 7.5, 100 mM
NaCl, 5 mM EDTA and Roche protease inhibitors cocktail) and processed
for pull-down using streptavidin beads.
Total internal reflection fluorescence microscopy
Live-cell imaging of plasma membrane VEGFR2 was accomplished by
TIRF-M. Cells were analysed using a Leica AM TIRFMC set up on a Leica
DMI6000 B microscope and a Leica 100X HCX PL APO 1.4 NA objective.
For live-cell TIRF-M analysis, the medium of HUVECs transfected with
a VEGFR2–mCherry expression plasmid was replaced with microscopy
solution, cells were transferred to a 37°C chamber and analysed by TIRF-M
(48 h post transfection). During analysis, dynasore and VEGF were added
sequentially at the indicated time points.
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Electron microscopy
HUVECs were stimulated with VEGF for 10 or 20 min and fixed in 4%
formaldehyde and 0.1% glutaraldehyde in 1x PHEM buffer for 60–90 min.
Cryo-sectioning and immuno-labelling was performed as described
previously (Schmidt et al., 2011). In brief, ultrathin sections (50–70 nm)
from gelatin-embedded and frozen cell pellets were obtained using an FC7/
UC7-ultramicrotome (Leica, Vienna, Austria). Immunogold labelling was
carried out in thawed sections using rabbit anti-VEGFR2 cytoplasmic
domain antibodies (1:20) and 5-nm protein-A-conjugated gold (UMC
Utrecht University, Utrecht, The Netherlands; 1:50). A mixture of uranyl
acetate and methyl cellulose was used for embedding and negative staining.
Sections were examined using a CM10 Philips transmission electron
microscope with an Olympus ‘Veleta’ 2kx2k side-mounted TEM CCD
camera. For the counting of gold particles, we used the stereology method,
by systematic uniform random sampling, in 2D space.
Surface VEGFR2 ELISA
Previous studies had developed protocols for the measurement of surface
antigens using the cell-surface ELISA technique (Bator and Reading,
1989; Smith et al., 1997). Here, we established the conditions for the
measurement of VEGFR2 on the surface of HUVECs. In brief, HUVECs
cultured in 96-well dishes were treated with inhibitors, stimulated with
VEGF for 30 min, washed three times with PBS and fixed with 3.7%
paraformaldehyde for 20 min. Non-specific sites were blocked with 1%
BSA in PBS (blocking buffer) for 1 h. Cells were incubated for 2 h with
goat anti-VEGFR2 extracellular domain antibodies (R&D Systems,
AF357, 1.5 μg/ml in blocking buffer), washed five times with blocking
buffer and treated with HRP-coupled anti-goat-IgG secondary antibodies
for 1 h. Subsequently, the cells were washed five times and the reaction
was initiated by the addition of 250 μl of substrate buffer (20 mg o-
phenylenediamine in 50 ml phosphate-citrate buffer, pH 5.0,
supplemented with 20 μl 30% H2O2). The reaction was terminated by
the addition of 50 μl of 2 mol/l H2SO4 and the absorbance was measured
at 492 nm. Measured values were normalised according to the total protein
in samples that were treated in parallel and lysed before the fixation step of
the assay. For siRNA experiments, cells were cultured and transfected in
24-well dishes. At 48 h post transfection, cells were detached using
trypsin, seeded confluent in 96-well plates and assayed after 24 h. Non-
stimulated cells were processed in parallel.
Spheroid sprouting, migration and MTT assays
The generation of HUVEC spheroids was performed according to a
previously described protocol (Korff and Augustin, 1999). Briefly, siRNA-
treated cells were trypsinised at 24 h post transfection and HUVEC spheroids
were generated using a defined number of cells (600 cells), for 24 h, in
hanging drop cultures, in cell growth medium supplemented with 0.24%
(w/v) carboxylmethylcellulose. Spheroids were harvested and embedded in
500 μl of rat type I collagen gels [supplemented with M199 medium, 10%
fetal calf serum (FCS) and 0.24% (w/v) carboxylmethylcellulose] and were
stimulated with 50 ng/ml VEGF (in 100 μl of M199 medium, on top of the
gels) for 16 h. In the case of EIPA treatment, EIPA (50 μΜ) was added to the
gels in combination with VEGF. Images of spheroids were captured with a
Leica DMI6000 B microscope and spheroid sprouting was analysed using
ImageJ software.
Migration of endothelial cells was assessed with a wound healing assay.
Confluent HUVECmonolayers grown in 24-well plates were serum-starved
for 6 h in M199 medium supplemented with 2% FCS, and linear scratch
injuries were applied with a 200 μl plastic pipette tip. Cells were washed
three times with HBSS and treated with 50 ng/ml VEGF in serum starvation
medium for 14 h. Non-stimulated cells were analysed in parallel. In the case
of treatment with EIPA, cells were pre-incubated with 50 μM EIPA for
30 min prior to the addition of VEGF. Images of random injury areas were
acquired at 0 and 14 h using a Leica DMI6000 B microscope. Migration of
endothelial cells was analysed using ImageJ software.
Survival of endothelial cells was determined by anMTTassay. At 24 h post
transfection, siRNA-treated HUVECs were trypsinised and seeded in 96-well
plates at a density of 6×103 cells. The next day, cells were serum starved for
24 h in M199 medium supplemented with 2% FCS. Then, the medium was
supplemented with 50 ng/ml VEGF (VEGF was replenished every 24 h) and
cells were incubated for 48 h. At the end of the incubation, cells were treated
with 0.5 mg/ml 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT), for 4 h, at 37°C. Then, the medium was aspirated, and
formazan crystals were dissolved by the addition of 200 μl of DMSO.
Subsequently, plates were agitated gently and the optical density was
measured at 570 nm. Untreated cells were analysed in parallel.
In vivoMatrigel and rabbit cornea angiogenesis assay
Animal experiments were been performed in accordance with the guidelines
of the European Commission for animal care and welfare (Directive 2010/
63/EU) and the local and national ethical committees.
The Matrigel plug assay was employed as described previously
(Finetti et al., 2008). VEGF, in the presence of EIPA, was diluted in
Matrigel (Becton Dickinson, growth factors and phenol red-free) on ice.
Final drug concentrations were 500 ng/plug VEGF and 50 µmol/l EIPA.
C57/B6J mice (12 weeks old, 15 animals in total) were subcutaneously
injected in the dorsal midline region with 0.4 ml of Matrigel alone or
with Matrigel containing the stimuli. After 7 days, the mice were killed
and implants were harvested. Plugs were re-suspended in 1 ml of
Drabkin’s reagent (Sigma), for 18 h on ice, and haemoglobin
concentration was determined by absorbance at 540 nm and compared
with a standard curve (Sigma).
Angiogenesis was studied in the cornea of male New Zealand white
rabbits (n=8, Charles River) as described previously (Monti et al., 2013).
Animals were anaesthetised by an intramuscular (i.m.) injection of 2%
xilazine (0.5 ml/animal) and tiletamine and zolazepam (10 mg/kg). The
depth of anaesthesia was checked as reflex to pressure. Each eye was
enucleated by the use of a dental dam, and a local anaesthetic (i.e. 0.4%
benoxinate) was instilled on the ocular surface just before surgery. The pellet
implantation procedure started with a linear intrastromal incision using a
surgical blade. The preparation of the corneal pocket for the pellet implant
was made in the lower half of the cornea with a 1.5 mm pliable silver spatula
with a smoothed blade edge. Pellets were implanted at 2 mm from the
limbus to avoid false positives due to the mechanical stress and to favour
gradient diffusion of test substances in the tissue towards the endothelial
cells at the limbal plexus. To test the effect of EIPA (12.5 μg/pellet), a fully
competent dose of VEGF (200 ng/pellet) was administered in the presence
of the inhibitor, being the two substances released from separate and
adjacent pellets. The corneas were observed and digital images were taken
by means of a slit-lamp stereomicroscope.
Quantifications
The quantification of immunoblots and immunofluorescence images was
performed using the ImageJ software. For the analysis of the number and the
size of VEGFR2-positive vesicles, vesicles were categorised in groups
based on their size, where each group should contain at least 10 vesicles, in
VEGF-stimulated cells. For in vivo experiments, angiogenic score (number
of progressing vessels/mm2) was calculated during time in a blind manner
by the use of ImageJ. In the case of electron microscopy experiments, for
each time point (10 and 20 min, three times each, on two different sample
grids), a total number of 250 gold particles were counted by meandering
scanning. Five cell components were assumed (plasma membrane, vesicles
0.2 μm<, vesicles >0.2 μm, nucleus, mitochondrion) for counting. In the
ELISA-like assay of surface VEGFR2, an immobile fraction of VEGFR2
(40% of total), which does not internalise in the presence of VEGF, was
excluded from all values.
Statistical analysis
Data plotting and statistical analysis was performed in GraphPad Prism.
Statistical differences were evaluated by using a Student’s t-test, for two-
group comparison, or analysis of variance (ANOVA) followed by Dunnett’s
post hoc analysis (one-way ANOVA) or Bonferroni post-test analysis (two-
way ANOVA), for comparisons of more than two groups. The values
reported in the figures represent mean±s.d. calculated from at least three
replicates for each experimental setting.
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